On Friday 1st November 2024, investors and market participants can expect the release of Biodesix (NASDAQ: BDSX) third quarter financial results. This crucial announcement will be made before market open.
Financial analysts on Wall Street are predicting that the enterprise is expected to report an estimated per share $0.07 loss for the current quarter. Additionally, the company is anticipated to reveal a total revenue of $18.61 million during this period.
In comparison to the same quarter of the prior year, the company's financial statement showcased a per share of loss of $0.14. This was credited to the company's total revenue, which reached an impressive $13.49 million in that particular timeframe.
The company's yearly performance has been analyzed by Wall Street analysts, who have projected a total revenue of $71.21 million. Moreover, they anticipate the company to disclose loss of $0.35 per share for the fiscal year.
BDSX has scheduled a conference call on 1st November 2024 at 08:30 AM eastern time to discuss the third quarter financial results and other related information.
Biodesix (BDSX) closed Wednesday's regular trading session at $1.66, demonstrating a 0.61 percent advance. The stock fluctuated between $1.62 and $1.69 during the day, with a volume of 66.80 thousand shares.